Tianda Pharmaceuticals Limited

HK$0.08As of Sun 8 Nov 2026, 12:00 UTC
HKEX:0455Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR (15.15%)
Div yield —
ROE (14.89%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.17
PE TTM —
TSR TTM (39.26%)
Mkt cap HK$176.3M
ROIC (9.39%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0836
1.97%
(57.55%)
Hold 2|2|6|3|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
22.79%
26.39%
20.92%
10.42%
Revenue$M
8.468
8.826
8.671
8.612
(2.02%)
4.47%
1.47%
2.36%
Peers (US$22.49M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.789
(0.077)
(0.074)
EBIT/Intx
1.282
1.670
1.727
Own earn%
34.70
37.62
38.23
Sh yield%
38.58
47.60
48.10
Owners
Insiders/Inst%
5.55
53.53
Short interest%
3.29
SBC / revenue%
0.68
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
15–25
$1 testx
0.5
Incr. ROIC%
6